Orionis Biosciences
Total Raised
$79.5MInvestors Count
8Deal Terms
1Funding, Valuation & Revenue
5 Fundings
Orionis Biosciences has raised $79.5M over 5 rounds.
Orionis Biosciences's latest funding round was a Series B for $55M on October 19, 2022.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/19/2022 | Series B | $55M | Cormorant Asset Management, Novartis, and Undisclosed Investors | 5 | ||
4/3/2018 | Series A | |||||
1/30/2017 | Debt | |||||
10/5/2015 | Seed VC | |||||
Other Investors |
Date | 10/19/2022 | 4/3/2018 | 1/30/2017 | 10/5/2015 | |
|---|---|---|---|---|---|
Round | Series B | Series A | Debt | Seed VC | Other Investors |
Amount | $55M | ||||
Investors | Cormorant Asset Management, Novartis, and Undisclosed Investors | ||||
Valuation | |||||
Revenue | |||||
Sources | 5 |
Orionis Biosciences Deal Terms
1 Deal Term
Orionis Biosciences's deal structure is available for 1 funding round, including their Series A from April 03, 2018.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Orionis Biosciences Investors
8 Investors
Orionis Biosciences has 8 investors. Novartis invested in Orionis Biosciences's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/19/2022 | 10/19/2022 | 1 Series B | Corporation | Switzerland | ||
Asset/Investment Management | Massachusetts | |||||
Venture Capital | Massachusetts | |||||
Angel Investor (Group) | New York | |||||
Venture Capital | Belgium |
First funding | 10/19/2022 | ||||
|---|---|---|---|---|---|
Last Funding | 10/19/2022 | ||||
Investor | |||||
Rounds | 1 Series B | ||||
Board Seats | |||||
Type | Corporation | Asset/Investment Management | Venture Capital | Angel Investor (Group) | Venture Capital |
Location | Switzerland | Massachusetts | Massachusetts | New York | Belgium |
Loading...